Multiplexed LC-ESI-MRM-MS-based Assay for Identification of Coronary Artery Disease Biomarkers in Human Plasma.
Mohammad A AnwarDarlene Liying DaiJanet Wilson-McManusDerek SmithGordon A FrancisChristoph H BorchersBruce M McManusJohn S HillGabriela V Cohen FreuePublished in: Proteomics. Clinical applications (2019)
If externally validated, the assay and identified biomarkers can improve CAD risk stratification.
Keyphrases
- coronary artery disease
- ms ms
- high throughput
- mass spectrometry
- percutaneous coronary intervention
- multiple sclerosis
- coronary artery bypass grafting
- cardiovascular events
- single cell
- simultaneous determination
- liquid chromatography
- cardiovascular disease
- type diabetes
- high resolution
- acute coronary syndrome
- aortic stenosis
- bioinformatics analysis
- ejection fraction